TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, launched and announced it has secured $15 million in Series A financing. Leading venture capital firms Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners co-led the investment in TARIS, which was founded by internationally renowned scientists from the Massachusetts [...]
TARIS's tag archives
TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies
Posted by Dana in June 27th 2009
Recent Articles
-
- Vertex Pharmaceuticals Reports Second Quarter 2010 Financial Results and Highlights Recent Business and Clinical Progress
- AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
- CardioNet, Inc. Reports Second Quarter 2010 Financial Results
- NPS Pharmaceuticals to Report Second Quarter 2010 Financial Results
- BioAlliance Pharma SA: A Record Turnover for Q2 2010 Reflecting the Successful US FDA Approval
- HealthStream Announces Second Quarter 2010 Results
- Simulations Plus Reports Third Quarter FY2010 Financial Results
- ZOLL Medical Corporation to Announce Third Quarter Results
- AngioDynamics Reports Strong Finish to Fiscal 2010
- Cubist Pharmaceuticals 2Q10 Total Net Revenues Up 29% to $168.5 Million
- Furiex Pharmaceuticals Announces Second Quarter 2010 Earnings Release and Conference Call
- Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Second Quarter Ended June 30, 2010
- Biomet Announces Fourth Quarter and Fiscal Year 2010 Financial Results
- Allergan Announces Quarterly Conference Call
- Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2010
